The NSEL chief said the exchange is also seeking the help of the Delhi government.
The FMC had warned MCX that it would not renew contracts, allow new contracts and eventually take away the licence to run the bourse if the commodity exchange does not comply with regulatory norms.
.jpg)
FTIL group is in big trouble after over Rs 5,500 crore payment crisis surfaced at its subsidiary NSEL last year.
The FMC on Thursday barred the National Spot Exchange and group firms from auctions of commodities held by the bourse after a complaint that firms related to the former managing director took part in the bidding process.
The company's accounts were audited by CAG as its shareholders include public sector banks.
MCX-SX on Friday said the rights issue would now close on April 17.
FMC approves commodity bourse's contract-launch calendar for two years.
The cash segment turnover at MCX-SX sharply fell to Rs 624 crore (Rs 6.24 billion) in November from Rs 1,119 crore (Rs 11.19 billion) in October, 2013.
Jignesh Shah, the promoter of National Spot Exchange Ltd (NSEL), and its former CEO Anjani Sinha on Friday traded charges in connection with the multi-crore payment crisis at the crippled bourse which has affected over 13,000 investors.
The Ministry's decision comes more than a year after the payment scam at NSEL came into light in July 2013.
It will be the first to go, in what has become an overcrowded segment since India first allowed futures trading in commodities in 2003.
Chary also says some government officials have played an important role in favouring organisations that MCX competes with.
FTIL prepares to challenge the order in the Bombay high court
Lack of consensus on 'how not to let Jignesh Shah get away' could become a huge embarrassment for the government.
Case relates to alleged irregularities in '08 sanction to MCX-SX; Shah grilled in NSEL case.
Few top honchos of India Inc did very well in 2014.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances